Automated pharmaceutical regulatory compliance tool that helps bring medicines to market more efficiently.

CBA is a boutique life science and healthcare management consulting firm focused on growth strategies for companies in the device, diagnostics, life science tools, and pharmaceutical sectors.

Welcome to our consulting company, where we specialize in software development and advanced analytics for pharma and medical device companies. With our extensive expertise, network, and experience, we assist our clients in selecting and leveraging the most relevant technologies to maximize their business potential and enhance the quality of healthcare. As pioneers in the field, we conduct our own research and development and hold an active patent (see WO2015086575A1), allowing us to offer unparalleled insights and solutions to our clients.

Our AI-driven platform fuses quantum physics, machine learning, and high-performance cloud computing to simulate crystal formation and address one of pharma’s most critical challenges: polymorphism. The impact? Weeks instead of months. Certainty over guesswork. Global Pharmaceutical leaders trust us to reduce risk, accelerate timelines, and boost the success rate of new drugs. Backed by Enterprise Ireland, the EIC Accelerator, and strategic partners like Viridien (formerly CGG), we’re scaling fast. Follow along as we change how the world brings medicines to life.

Adaptive Intelligence is the next evolution of decision support in life sciences. Kognitic unifies global data, evidence, and competitor activity into a modular workflow that adapts to each team’s needs. Every view is customizable, every path is flexible, and every insight is guided, giving users a single connected way to uncover the story they need from public data, news, trials, and more. From early development through late stage strategy, Kognitic helps leaders anticipate change, align faster, and execute with clarity.

VivproAI offers a revolutionary biointelligence software platform and innovative services to make evidence-based clinical, regulatory, and business decisions at lightning speed for pharmaceutical, biotech, device developers, CROs, and investors.

Life Sciences Review is a trusted print and digital magazine delivering news, insights and expert opinions on advancements in biotech, pharma and medical devices. We provide thoughtfully curated articles on the latest technologies and best practices that make organizations competitive, agile and future-ready.

Involve Data was founded on a simple yet ambitious mission: to transform how life science organizations harness the power of technology and data. From our beginnings, we’ve grown into a trusted partner for biotech and pharmaceutical companies worldwide, driven by a commitment to innovation, integrity, and measurable impact. By blending cutting-edge expertise with a deep understanding of scientific processes, we empower organizations to achieve breakthroughs faster.

We develop innovative digital solutions to enable next-gen clinical trials.

Burrard Pharmaceuticals is an international leading biopharmaceutical company. We have access to modern state-of-the-art pharmaceutical facilities. The operational efficiency of our facility results in diverse production options, reduced lifecycle costs and compliance to all pharma GMP regulations. We have extensive expert resources combining unique processes and full technology integration. Since our founding in 2005, we are at the forefront of drug manufacturing and technology transfer. Burrard Pharmaceuticals has developed a comprehensive portfolio of oncology, and injections products. We bring together experts dedicated to offer a variety of pharmacological services. With the knowledge and expertise to complete all kind of drug formulations, we strive to be your trusted partner in achieving phenomenal success. Whether you are looking for a custom solution or project needs for your pharmaceutical products, we can maximize your return on investment, all the way from drug discovery to manufacturing.

SagaReg simplifies the creation of pharmaceutical dossiers using artificial intelligence and specialized software. The solution automates text writing, table creation and reviews, ensuring faster and more reliable applications to health authorities.

CurifyLabs is a healthtech company building solutions for automated compounding of personalized medicines in pharmacies and hospitals. We’re transforming a traditionally manual, time-intensive workflow into a streamlined, efficient, and accurate process—helping pharmacists deliver patient-specific therapies with compliance by design. Our Compounding System Solution (CSS) is an automated platform for non-sterile compounding. CSS combines GMP-manufactured excipient bases, compounding robotics inspired by 3D printing, integrated in-process quality control, software, and a comprehensive formulation library—supporting consistent quality, improved efficiency, and better patient access. CSS is in clinical use with customers in Europe and the US, enabling pharmacies and hospital pharmacies to compound faster and more safely, with high standards built into the workflow. CurifyLabs was founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius.

We’re your trusted partner in revolutionizing healthcare. We collaborate with forward-thinking leaders and startups in healthcare and life sciences to deliver cutting-edge solutions that improve patient outcomes and optimize operational efficiency. OUR PURPOSE Our purpose is to revolutionize healthcare and enhance patient lives by driving innovation and advancing digital transformation. We envision a future where technology and science converge to deliver superior patient outcomes worldwide. OUR VISION & MISSION “Transforming Health, Empowering Innovation.” Our mission is to empower healthcare and life sciences companies through transformative digital solutions, regulatory expertise, and strategic insights. We are committed to driving innovation, enhancing patient outcomes, and fostering collaboration to shape a future where technology transforms global health and well-being.

At CoreKode, we specialize in developing cutting-edge SaaS products that leverage the power of AI to transform businesses. Our solutions are designed to automate workflows, enhance decision-making, and deliver personalized experiences, helping companies optimize operations and stay ahead in the digital era. Whether it's intelligent data analysis, AI-driven customer support, or predictive insights, CoreKode empowers businesses to innovate and scale with smart, efficient technology.

EuroPharMedTech (EPMT) helps biopharma teams turn data, science, and regulation into real‑world impact. We combine market access strategy, medical and regulatory expertise, and AI‑driven solutions to accelerate decisions, strengthen evidence, and support compliant growth. Our team brings hands‑on experience across Health Technology Assessment (HTA), pharmacovigilance, medical affairs, medical writing, real‑world evidence and data computing, and IT & AI enablement for SMEs. We also build SaaS tools including our CLEVAIR‑HTA platform. This platform streamline evidence reviews, automate research workflows, and keep teams aligned with evolving EU requirements. Headquartered in Brussels and working across Europe and the U.S., we partner with pharmaceutical SMEs and innovators to deliver practical, compliant solutions that improve time‑to‑insight, reduce operational burden, and keep the focus on patient value. What we deliver: market access and HTA support; medical, regulatory, and technical writing; pharmacovigilance; medical affairs and medical information & publicity; data computing & RWE; IT & AI support for SMEs; EU AI Act readiness; and training & eLearning for your teams.

Medivant Pharma is a leading clinical service organization dedicated to advancing healthcare and improving patient outcomes. With a strong focus on research, innovation, and patient-centric solutions, we collaborate with pharmaceutical companies, biotech firms, and research institutions to accelerate drug development and enhance clinical trial efficiency.

Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.

Vernus AI is a global leader in Pharmaceutical AI and Quantum Computing, dedicated to revolutionizing the world of drug manufacturing. Through our revolutionary ReAIX platform, we bridge the gap between cutting-edge technology and deep scientific expertise. By training top-tier Large Language Models (LLMs) with specialized domain knowledge, we have built a suite of expert AI Agents specialized in Chemistry, Biology, and Pharmaceutics. Our Innovation Strategy We leverage Quantum Digital Annealing and multi-scale simulations to generate robust synthetic data. This allows us to create high-fidelity Digital Twins that: •Optimize complex manufacturing processes •Significantly increase production yields •Solve the industry’s most intricate scale-up challenges A Global Partner in Drug Development Vernus AI is more than just a software provider. We are a dual-model international AI powerhouse: •AI Software Services: Providing the tools to unlock new levels of industrial productivity. •Pipeline Development: Collaborating on joint drug development projects with world-class and domestic pharmaceutical leaders. At Vernus AI, we are committed to unlocking the next generation of productivity for the global pharmaceutical industry.

Accolade Analytical delivers high-quality, science-driven analytical and CMC solutions that accelerate drug development, ensure regulatory compliance, and support success for pharmaceutical and biotech partners. Through innovation, integrity, and collaboration, we empower clients to bring therapies to market with confidence. Our lab provides seamless access to a comprehensive suite of state-of-the-art analytical and solid-state characterization techniques. Core instrumentation includes PXRD, NMR, SEM, DSC, and TGA, along with advanced tools such as FTIR, Raman spectroscopy, Solid-State UV-Vis, Hot Stage Microscopy, XPS, AFM, BET surface area analysis, XRPD with Rietveld refinement, DVS, SSNMR, powder rheometry, and ellipsometry. Accolade also offers robust HPLC method development and validation, LC-MS, and ICP-MS capabilities for small and large molecules. Our services support impurity profiling, metabolite identification, stability studies, and elemental analysis to ensure comprehensive data across the product lifecycle. We also provide pharmacokinetic/pharmacodynamic (PK/PD) analysis and bioanalytical support to guide dose selection and regulatory strategy. All instruments are certified and maintained by experienced technicians to deliver high-integrity, reliable data. Clients benefit from fast project initiation, expert consultations, and reduced turnaround times. By relieving operational burdens, Accolade enables teams to focus on core R&D priorities. With regulatory-ready reports and expert data interpretation, we foster strategic partnerships and deliver actionable insights that drive innovation and regulatory success.

Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.

U.S. Pharma Consulting (USPC) offers a comprehensive spectrum of expertise and services for your pharma business and product portfolio solution needs. Our team offers in-depth pharmaceutical industry experience with expertise in commercialization, business development (In/Out licensing strategies), generic Rx pharmaceutical (505 j), Rx authorized generics, brand Rx pharmaceuticals (505 b1/505 b2/503 a/503 b), medical foods, dietary supplements, and OTC products. Our primary business focus is molecules or device to market and most importantly the market back to molecule or device. USPC offers a universally recognized team of consultant experts with a one-on-one entrepreneurial boutique business approach and a level of sophistication. We are passionate about and dedicated to building a diverse and inclusive consulting experience. Our team is comprised of in-house consultants’ experts and a network of consulting team leaders throughout USPC global hub network. If you are seeking a project delivery leader, then you are one click away from a committed team of experts as a strategic asset to your business consulting projects. Please contact us today for more information.

Developer of an AI-enhanced predictive platform designed to assist pharmaceuticals with the development of drugs. The company's platform uses a combination of molecular chemistry, quantum physics, and artificial intelligence computing for crystal-structure prediction, enabling researchers to predict the stable polymorph, bringing speed, certainty, and product data quality.

In the rapidly evolving world of healthcare and life sciences, technology is at the heart of innovation—driving breakthroughs in patient care, medical research, and operational efficiency. At Catalyst Technology Partners, our fractional and interim CTOs bring decades of industry expertise to help healthcare organizations, biotech firms, and pharma companies navigate complex technology, data, compliance, and digital transformation challenges. From AI-driven diagnostics and clinical data management to HIPAA-compliant cloud infrastructure and cybersecurity, we provide on-demand technology leadership to ensure your organization remains competitive, scalable, and secure. Whether you're a health-tech startup, research institution, or global pharmaceutical company, we help you build and execute a future-proof IT strategy that accelerates innovation and delivers measurable impact. Partner with Catalyst Technology Partner’s healthcare and life sciences CTOs to harness the power of technology for better patient outcomes, streamlined operations, and industry-leading advancements.

ClinMed leverages decades of experience in global medical research, patient-focused drug development, digital health, and consortia-driven approaches. By combining scientific rigor and market creativity, we help organizations from the biotechnology, pharmaceutical, health technology, and medical cannabis industries with a broad range of services: - Clinical Research - Medical Affairs - Indication Vetting - Life Cycle Management - Product & HEOR Strategies - Communications/Publications - Advisory Boards - Business Development